Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma.

While cells were treated with the combination of carfilzomib with vorinostat, there was a highly significant increase in the G 2 -M phase population, compared to treatment with carfilzomib alone ( n = 3, P < 0.005).

also in 132,142 other papers